WO2025074310 - ENGINEERED RETROTRANSPOSABLE ELEMENT PROTEINS FOR GENE DELIVERY AND INSERTION
National phase entry:
Publication Number
WO/2025/074310
Publication Date
10.04.2025
International Application No.
PCT/IB2024/059702
International Filing Date
03.10.2024
Title **
[English]
ENGINEERED RETROTRANSPOSABLE ELEMENT PROTEINS FOR GENE DELIVERY AND INSERTION
[French]
PROTÉINES D'ÉLÉMENT RÉTROTRANSPOSABLES MODIFIÉES POUR LA DISTRIBUTION ET L'INSERTION DE GÈNES
Applicants **
AVERNA THERAPEUTICS LTD
Inventors
TRUDEAU, Devin
BEN SHUSHAN GOLECZKI, Yaron
GORDON, Aaron
KOWALSMAN, Noga
GABAY, Orshay
Priority Data
63/588,418
06.10.2023
US
63/558,395
27.02.2024
US
63/640,141
29.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 11301 | |
| EPO | Filing, Examination, Granting | 216175 | |
| Japan | Filing, Examination, Granting | 5286 | |
| South Korea | Filing, Examination, Granting | 12641 | |
| USA | Filing, Examination, Granting | 50140 |
Total:
295,543
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure provides compositions and methods for enhancing the integration of a transgene into a genome.[French]
La présente divulgation concerne des compositions et des procédés permettant d'améliorer l'intégration d'un transgène dans un génome.